Last reviewed · How we verify

NCT03246243

Quantitative Assessment of Sucking for Early Diagnosis of Brain Injury in Infants at High Risk

Terminated Last updated 21 May 2021
What this trial tests

trial testing nfant feeding solution in Hypoxic-Ischemic Encephalopathy in 16 participants. Terminated before completion.

Timeline
29 March 2017
Primary endpoint
18 May 2021
18 May 2021

Quick facts

Lead sponsorBoston Children's Hospital
StatusTerminated
Study typeOBSERVATIONAL
Enrollment16
Start date29 March 2017
Primary completion18 May 2021
Estimated completion18 May 2021
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Boston Children's Hospital

Who can join

Under 6 Months, any sex, with Hypoxic-Ischemic Encephalopathy or Hypoglycemia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main goal of this study is to quantitatively assess the sucking and feeding activity of infants at high risk of neurological impairment (preterm infants and term infants at risk of abnormal neurodevelopment) during oral sucking and feeding and correlate it with their underlying neurological impairment for the early diagnosis of brain injury.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Hypoxic-Ischemic Encephalopathy

Currently open trials in the same condition.

Other Boston Children's Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03246243.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing